SCHEMBL30306703

SCHEMBL30306703

O=C1C=C(c2c(C3CCN(Cc4ccccn4)CC3)[nH]c3ccccc23)C(=O)N1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TLR9 Q9NR96 1/20 0.42
TLR8 Q9NR97 1/20 0.42
TLR7 Q9NYK1 1/20 0.42
PRKCG P05129 2/20 0.42
PRKCB P05771 2/20 0.42
PRKCA P17252 2/20 0.42
PRKCE Q02156 2/20 0.42
CDK9 P50750 2/20 0.42
PIP5K1C O60331 1/20 0.42
RPS6KA5 O75582 1/20 0.42
RPS6KA4 O75676 1/20 0.42
STK16 O75716 1/20 0.42
PAK3 O75914 1/20 0.42
CDK14 O94921 1/20 0.42
MET P08581 1/20 0.42
PDGFRB P09619 1/20 0.42
KIT P10721 1/20 0.42
PIM1 P11309 1/20 0.42
FGFR1 P11362 1/20 0.42
PRKACA P17612 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7524369 0.74 PRKCG (0.69) PRKCGPRKCBPRKCAPRKCECDK9
SCHEMBL6438378 0.72 L3MBTL1 (0.47) TLR9TLR8TLR7CDK9L3MBTL1
SCHEMBL3150985 0.63 KDM4E (0.65) L3MBTL1KDM4ESMN1; SMN2ALDH1A1CYP2C19
SCHEMBL29992091 0.63 CYP1A2 (0.71) L3MBTL1KDM4ESMN1; SMN2ALDH1A1DDB1
SCHEMBL20804356 0.63 CYP1A2 (0.71) L3MBTL1KDM4ESMN1; SMN2ALDH1A1DDB1
SCHEMBL1333260 0.63 CYP1A2 (0.71) L3MBTL1KDM4ESMN1; SMN2ALDH1A1DDB1
SCHEMBL1331974 0.63 CYP1A2 (0.71) L3MBTL1KDM4ESMN1; SMN2ALDH1A1DDB1
SCHEMBL30141847 0.63 CYP1A2 (0.71) L3MBTL1KDM4ESMN1; SMN2ALDH1A1DDB1
SCHEMBL13456363 0.63 L3MBTL1 (0.62) L3MBTL1KDM4ESMN1; SMN2ALDH1A1CYP2C19
SCHEMBL2495181 0.63 L3MBTL1 (0.62) L3MBTL1KDM4ESMN1; SMN2ALDH1A1CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4171637-A1 THERAPEUTIC TREATMENT USING PROTEIN KINASE C (PKC) INHIBITORS AND CYTOTOXIC AGENTS Cambridge Enterprise Limited (GB) 2023-05-03 EP disclosed